Pop the Quark

FRAMINGHAM (01/15/2004) - Andre G. Pernet takes over as president at Quark Biotech Inc., a privately held company pioneering endpoint-driven drug development (ED3), described as a vertically integrated development approach. Pernet is currently the chairman of CURx Pharma Inc.

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.
Show Comments